MORGAN STANLEY

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$47,239,125

-$6,410,581 QoQ

Shares Held

913,893

-15.3% QoQ

Ownership

1.57%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 83.14102416803718.ToString("F0")% Shared 0.ToString("F0")% None 16.858975831962823.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $4,148,184,090 across 73 Drug Manufacturers - Specialty & Generic names. SUPN ranks #17 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	14,145,735	$1,672,167,321
2	UTHR	UNITED THERAPEUTICS Corp	409,288	$242,699,592
3	TEVA	Teva Pharmaceutical Industries Ltd	7,426,253	$223,678,734
4	VTRS	Viatris Inc	16,089,939	$217,375,067
5	HLN	Haleon plc	19,166,253	$191,854,187
6	HIMS	Hims & Hers Health, Inc.	8,889,088	$184,537,462
7	NBIX	Neurocrine Biosciences Inc	1,219,196	$160,616,870
8	ELAN	Elanco Animal Health Inc	6,417,527	$153,571,413

All Filings in SUPN

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$47,239,125	913,893	-15.3%	Shares	Defined	2026-05-15
2025-12-31	$53,649,706	1,079,471	+42.9%	Shares	Defined	2026-05-27
2025-09-30	$36,096,596	755,317	+8.9%	Shares	Defined	2026-05-27
2025-06-30	$21,867,060	693,752	+6.8%	Shares	Defined	2025-08-15
2025-03-31	$21,282,191	649,838	-4.1%	Shares	Defined	2025-05-15
2024-12-31	$24,504,435	677,667	-6.7%	Shares	Defined	2025-05-15
2024-09-30	$22,640,199	726,113	+8.3%	Shares	Defined	2025-05-14
2024-06-30	$17,937,665	670,567	+3.1%	Shares	Defined	2025-05-14
2024-03-31	$22,179,206	650,226	-10.1%	Shares	Defined	2024-10-17
2023-12-31	$20,933,889	723,355	+36.8%	Shares	Defined	2024-08-16
2023-09-30	$14,572,920	528,579	-4.9%	Shares	Defined	2023-11-15
2023-06-30	$16,710,290	555,898	+2.8%	Shares	Defined	2023-08-14
2023-03-31	$19,596,260	540,885	-26.0%	Shares	Defined	2023-05-15
2022-12-31	$26,054,897	730,443	+41.6%	Shares	Defined	2023-02-14
2022-09-30	$17,457,593	515,734	+8.8%	Shares	Defined	2022-11-14
2022-06-30	$13,708,914	474,029	+103.7%	Shares	Defined	2022-10-27
2022-03-31	$7,520,991	232,704	-16.3%	Shares	Defined	2022-10-27
2021-12-31	$8,107,993	278,052	+23.7%	Shares	Defined	2022-02-14
2021-09-30	$5,994,265	224,757	-14.6%	Shares	Defined	2021-11-15
2021-06-30	$8,101,739	263,129	+35.2%	Shares	Defined	2021-08-23
2021-03-31	$5,096,486	194,671	-14.8%	Shares	Defined	2021-05-17
2020-12-31	$5,750,593	228,561	-43.4%	Shares	Defined	2021-02-16
2020-09-30	$8,420,130	404,037	-34.8%	Shares	Defined	2020-11-13
2020-06-30	$14,720,866	619,826	-45.7%	Shares	Defined	2020-08-14
2020-03-31	$20,546,538	1,142,109	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.